Raymund Breu (1945), Swiss
Member, non-executive and independent
Raymund Breu started in group treasury at Sandoz in 1975, rising to Chief Financial Officer of Sandoz Corporation in New York in 1985. In 1990, he became Group Treasurer of Sandoz Ltd and in 1993 Head of Group Finance and a member of the Executive Board. From 1996 to 2010, he was Chief Financial Officer and member of the Executive Committee of Novartis. Raymund Breu was elected to Swiss Re’s Board of Directors in 2003 and is a member of the Audit Committee and the Investment Committee.
- Board member of Nobel Biocare Holding AG
- Member of the Swiss Takeover Board
- PhD in Mathematics, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland